Martin Picard, PhD, associate professor of behavioral medicine, developed a technique that allowed to digitize & quantify the subtle changes in hair color. The gathered data revealed a pattern.
Drs. Bell and Ader will conduct a feasibility study titled, "Intervention to capture the diagnostic potential of individuals in a group-based learning or clinical environment."
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
